Biofrontera AG’s $12 million American depositary shares (ADSs) Initial Public Offering

Schiff Hardin advised The Benchmark Company as managing underwriter in the transaction The shareholders of the dermatology-focused biotechnology company have pre-emptive rights under German law and…